Differential roles of Alzheimer's disease plasma biomarkers in stepwise biomarker-guided diagnostics

被引:0
|
作者
Jang, Hyemin [1 ]
Shin, Daeun [2 ]
Yoo, Heejin [2 ]
Zetterberg, Henrik [3 ,4 ,5 ,6 ,7 ,8 ]
Blennow, Kaj [3 ,4 ,9 ,10 ,11 ,12 ]
Gonzalez-Ortiz, Fernando [3 ,4 ]
Ashton, Nicholas J. [3 ,13 ,14 ,15 ,16 ]
Day, Theresa A. [17 ]
Lee, Eun Hye [2 ]
Yun, Jihwan [18 ]
Na, Duk L. [2 ]
Kim, Hee Jin [2 ,19 ,20 ,21 ]
Kang, Sung Hoon [22 ]
Kim, Ko Woon [23 ]
Kim, Si Eun [24 ]
Kim, Yeo Jin [25 ]
Kim, Yeshin [26 ]
Kim, Jaeho [27 ]
Kim, Chi-Hun [28 ]
Chun, Min Young [29 ,30 ]
Jung, Na Yeon [31 ]
Cho, Soo Hyun [32 ]
Kim, Jun Pyo [2 ]
Seo, Sang Won [2 ,19 ,20 ,21 ]
K-ROAD Study Grp
机构
[1] Seoul Natl Univ, Coll Med, Dept Neurol, Seoul Natl Univ Hosp, Seoul, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, 81 Irwon Ro, Seoul 06351, South Korea
[3] Univ Gothenburg, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Sahlgrenska Acad, Molndal, Sweden
[4] Sahlgrens Univ Hosp, Clin Neurochem Lab, Gothenburg, Sweden
[5] UCL, Dept Neurodegenerat Dis, Inst Neurol, Queen Sq, London, England
[6] UCL, UK Dementia Res Inst, London, England
[7] Hong Kong Ctr Neurodegenerat Dis, Clear Water Bay, Hong Kong, Peoples R China
[8] Univ Wisconsin Madison, Wisconsin Alzheimers Dis Res Ctr, Univ Wisconsin Sch Med & Publ Hlth, Madison, WI USA
[9] Sorbonne Univ, Pitie Salpetriere Hosp, Paris Brain Inst, ICM, Paris, France
[10] Univ Sci & Technol China, Affiliated Hosp USTC 1, Inst Aging & Brain Disorders, Hefei, Peoples R China
[11] Univ Sci & Technol China, Inst Aging & Brain Disorders, Dept Neurol, Hefei, Peoples R China
[12] USTC, Affiliated Hosp 1, Hefei, Peoples R China
[13] Kings Coll London, Maurice Wohl Clin Neurosci Inst, Inst Psychiat Psychol & Neurosci, De Crespigny Pk, London, England
[14] South London & Maudsley NHS Fdn Trust, NIHR Biomed Res Ctr Mental Hlth, De Crespigny Pk, London, England
[15] South London & Maudsley NHS Fdn, Biomed Res Unit Dementia, De Crespigny Pk, London, England
[16] Stavanger Univ Hosp, Ctr Age Related Med, Stavanger, Norway
[17] Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN USA
[18] Soonchunhyang Univ, Bucheon Hosp, Dept Neurol, Bucheon Si, Gyeonggi Do, South Korea
[19] Samsung Med Ctr, Alzheimers Dis Convergence Res Ctr, Seoul, South Korea
[20] Sungkyunkwan Univ, Dept Hlth Sci & Technol, SAIHST, Seoul, South Korea
[21] Samsung Med Ctr, Neurosci Ctr, Seoul, South Korea
[22] Korea Univ, Coll Med, Dept Neurol, Guro Hosp, Seoul, South Korea
[23] Jeonbuk Natl Univ, Med Sch & Hosp, Dept Neurol, Jeonju Si, South Korea
[24] Inje Univ, Coll Med, Haeundae Paik Hosp, Dept Neurol, Busan, South Korea
[25] Hallym Univ, Coll Med, Kangdong Sacred Heart Hosp, Dept Neurol, Seoul, South Korea
[26] Kangwon Natl Univ, Sch Med, Kangwon Natl Univ Hosp, Dept Neurol, Chuncheon Si, Gangwon Do, South Korea
[27] Hallym Univ, Coll Med, Dongtan Sacred Heart Hosp, Dept Neurol, Seoul, South Korea
[28] Hallym Univ, Coll Med, Dept Neurol, Sacred Heart Hosp, Anyang Si 431070, Gyeonggi Do, South Korea
[29] Yonsei Univ, Coll Med, Dept Neurol, Seoul, South Korea
[30] Yonsei Univ Hlth Syst, Yongin Severance Hosp, Dept Neurol, Yongin, Gyeonggi Do, South Korea
[31] Pusan Natl Univ, Yangsan Hosp, Res Inst Convergence Biomed Sci & Technol, Dept Neurol, Yangsan Si, Gyeongsangnam D, South Korea
[32] Chonnam Natl Univ, Chonnam Natl Univ Hosp, Med Sch, Dept Neurol, Gwangju, South Korea
基金
瑞典研究理事会; 新加坡国家研究基金会;
关键词
Alzheimer's disease; neurofilament light chain; positron emission tomography; plasma biomarker; p-tau217; PHOSPHORYLATED TAU 181; NEUROFILAMENT LIGHT; BLOOD BIOMARKERS; PROTEIN;
D O I
10.1002/alz.14526
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
INTRODUCTION This study aimed to investigate the differential roles of various plasma biomarkers in a stepwise diagnostic strategy for Alzheimer's disease (AD). METHODS A total of 2984 participants, including 666 cognitively unimpaired (CU), 2032 with Alzheimer's clinical syndrome (ACS), and 286 non-ACS individuals, were recruited. Plasma amyloid beta (A beta) 42/40, four phosphorylated tau (p-tau) epitopes, glial fibrillary acidic protein (GFAP), and neurofilament light chain (NfL) levels were measured using immunoassays. RESULTS NfL demonstrated fair to excellent accuracy in differentiating non-ACS from CU groups (area under the curve [AUC], 0.79 to 0.94). p-tau217 had the highest accuracy for identifying A beta (AUC 0.94) and tau positron emission tomography status (AUC 0.91). In the ACS group, p-tau217 was the strongest predictor of cognitive decline (p < .001). DISCUSSION NfL may serve as a useful screening tool, while p-tau217 is particularly valuable for confirming AD pathology and prognosis.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Plasma biomarker profiles in autosomal dominant Alzheimer's disease
    Johansson, Charlotte
    Thordardottir, Steinunn
    Laffita-Mesa, Jose
    Rodriguez-Vieitez, Elena
    Zetterberg, Henrik
    Blennow, Kaj
    Graff, Caroline
    BRAIN, 2023, 146 (03) : 1132 - 1140
  • [42] Identification of Cathepsin D as a Plasma Biomarker for Alzheimer's Disease
    Kim, Jae-Whan
    Jung, Soon-Young
    Kim, Youngbinz
    Heo, Hansol
    Hong, Chang-Hyung
    Seo, Sang-Won
    Choi, Seong-Hye
    Son, Sang-Joon
    Lee, Seongju
    Chang, Jaerak
    CELLS, 2021, 10 (01) : 1 - 13
  • [43] Electrochemical Detection of Plasma Immunoglobulin as a Biomarker for Alzheimer's Disease
    Garyfallou, Goulielmos-Zois
    Ketebu, Orlando
    Sahin, Samet
    Mukaetova-Ladinska, Elizabeta B.
    Catt, Michael
    Yu, Eileen Hao
    SENSORS, 2017, 17 (11):
  • [44] Specific protein biomarker patterns for Alzheimer’s disease: improved diagnostics in progress
    Illana Gozes
    EPMA Journal, 2017, 8 : 255 - 259
  • [45] Specific protein biomarker patterns for Alzheimer's disease: improved diagnostics in progress
    Gozes, Illana
    EPMA JOURNAL, 2017, 8 (03): : 255 - 259
  • [46] Blood Biomarkers: Democratizing Alzheimer's Diagnostics
    Zetterberg, Henrik
    Blennow, Kaj
    NEURON, 2020, 106 (06) : 881 - 883
  • [47] Plasma biomarkers for Alzheimer's
    Arnaud, Celia
    CHEMICAL & ENGINEERING NEWS, 2018, 96 (06) : 6 - 6
  • [48] Evaluation of Differential Diagnostics Potential of Uniform Data Set 2 Neuropsychology Battery Using Alzheimer's Disease Biomarkers
    Cihak, Martin
    Horakova, Hana
    Vyhnalek, Martin
    Veverova, Katerina
    Matuskova, Veronika
    Laczo, Jan
    Hort, Jakub
    Nikolai, Tomas
    ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2024, 39 (07) : 839 - 848
  • [49] Plasma Lipocalin 2 in Alzheimer's disease: potential utility in the differential diagnosis and relationship with other biomarkers
    Hermann, Peter
    Villar-Pique, Anna
    Schmitz, Matthias
    Schmidt, Christian
    Varges, Daniela
    Goebel, Stefan
    Bunck, Timothy
    Lindemann, Hanna
    Bogner, Carla
    Santana, Isabel
    Baldeiras, Ines
    Riggert, Joachim
    Zerr, Inga
    Llorens, Franc
    ALZHEIMERS RESEARCH & THERAPY, 2022, 14 (01)
  • [50] Plasma Lipocalin 2 in Alzheimer’s disease: potential utility in the differential diagnosis and relationship with other biomarkers
    Peter Hermann
    Anna Villar-Piqué
    Matthias Schmitz
    Christian Schmidt
    Daniela Varges
    Stefan Goebel
    Timothy Bunck
    Hanna Lindemann
    Carla Bogner
    Isabel Santana
    Inês Baldeiras
    Joachim Riggert
    Inga Zerr
    Franc Llorens
    Alzheimer's Research & Therapy, 14